Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement

被引:48
作者
Chism, DB [1 ]
Horwitz, EM [1 ]
Hanlon, AL [1 ]
Pinover, WH [1 ]
Mitra, RK [1 ]
Hanks, GE [1 ]
机构
[1] Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2003年 / 55卷 / 01期
关键词
prostate cancer; three-dimensional conformal radiotherapy; late morbidity;
D O I
10.1016/S0360-3016(02)03822-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To describe the frequency and magnitude of late GI and GU morbidity in prostate cancer patients treated to high dose levels with a simple three-dimensional conformal technique. Methods and Materials: A total of 156 intermediate- and high-risk patients were treated between January 1, 1992 and February 28, 1999 with a simple four-field three-dimensional conformal technique to 79 - 84 Gy. All patients were treated with a four-field conformal technique; the prostate received 82 Gy and the seminal vesicles and periprostatic tissue 46 Gy. GI and GU toxicity was scored according to the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer Late Morbidity Grading Scale and compared using Kaplan-Meier estimates. Results: The late Grade 2 GI complication rate was 9 % and 38% at 3 years for patients treated with and without rectal blocking, respectively (p = 0.0004). No Grade 3 late GI complications developed. The rate of Grade 2 late GU complications was 5%, 8%, and 12% at 12, 24, and 36 months, respectively. The Grade 3 late GU complication rate was 2% at 36 months. These differences were not statistically significant. Conclusion: The treatment method described is a simple four-field conformal technique that can be easily implemented in the general radiation community. A dose of 79-84 Gy can be safely delivered to the prostate, with a 9% rate of late Grade 2 GI, 12% rate of late Grade 2 GU, and 2% rate of late Grade 3 GU complications. (C) 2003 Elsevier Science Inc.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 16 条
[1]  
[Anonymous], 1997, Int J Radiat Oncol Biol Phys, V37, P1035
[2]   Patterns of care studies: Past, present, and future [J].
Hanks, GE ;
Coia, LR ;
Curry, J .
SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (02) :97-100
[3]   Dose selection for prostate cancer patients based on dose comparison and dose response studies [J].
Hanks, GE ;
Hanlon, AL ;
Pinover, WH ;
Horwitz, EM ;
Price, RA ;
Schultheiss, T .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (04) :823-832
[4]   Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales [J].
Hanlon, AL ;
Schultheiss, TE ;
Hunt, MA ;
Movsas, B ;
Peter, RS ;
Hanks, GE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (01) :59-63
[5]   Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: Comparing late bowel and bladder quality of life symptoms to that of the normal population [J].
Hanlon, AL ;
Bruner, DW ;
Peter, R ;
Hanks, GE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (01) :51-59
[6]  
Horwitz EM, 2001, CANCER, V92, P1281, DOI 10.1002/1097-0142(20010901)92:5<1281::AID-CNCR1449>3.0.CO
[7]  
2-9
[8]  
ICRU, 1993, 50 ICRU, V50, P3
[9]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[10]   Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason ≤ 6, and pretreatment prostate-specific antigen ≤ 10) [J].
Kupelian, PA ;
Buchsbaum, JC ;
Reddy, CA ;
Klein, EA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (03) :621-625